Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model

Antioxidants and Redox Signaling

Volumn 11, Issue 9, 2009, Pages 2289-2298

  Khan, Mohammad I ^a   Pichna, Branislav A ^a   Shi, Yuanyuan ^a   Bowes, Anna J ^a   Werstuck, Geoff H ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLUCOSAMINE; GLUCOSE; LIPID; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; LIPID BLOOD LEVEL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR TISSUE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; GLUCOSAMINE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MICE; OXIDATIVE STRESS; VALPROIC ACID;

MUS;

EID: 68949204489     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2569     Document Type: Article

References (43)

1. Basseri S, Lhotak S, Sharma AM, and Austin RC. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res Epub ahead of print May 21, 2009.
2. Bowes AJ, Khan MI, Shi Y, Robertson L, and Werstuck GH. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis. Am J Pathol 174: 330-342, 2009.
3. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, and Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 25: 406-409, 2000.
4. Elias D, Prigozin H, Polak N, Rapoport M, Lohse AW, and Cohen IR. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 43: 992-998, 1994.
5. Ellgaard L and Hellenius A. ER quality control: towards an understanding at the molecular level. Curr Opin Cell Biol 13: 431-437, 2001.
6. Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, Reid BN, Blaner WS, and Huang LS. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes 57: 1674-1682, 2008.
7. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97: 3A-11A, 2006.
8. Haffner SM, Lehto S, Ronnemaa T, Pyorala K and Laakso M. Mortality from coronary heart disease in subjects with type2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234, 1998.
9. Han I, Oh E, and Kudlow JE. Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem J 350: 109-114, 2000.
10. Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, and Ron D. Diabetes mellitus and exocrine pancreatic dysfunction in perk: mice reveals a role for translational control in secretory cell survival. Mol Cell 7: 1153-1163, 2001.
11. Hiroi T, Wei H, Hough C, Leeds P, and Chuang DM. Protracted lithium treatment protects against ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J. 5: 102-111, 2005.
12. Horwitz MS, Ilic A, Fine C, Rodriguez E, and Sarvetnick N. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 109: 79-87, 2002.
13. Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, and Austin RC. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death and contributes to the development of atherosclerosis in hyperhomocysteinemia. J Biol Chem 278: 30317-30327, 2003.
14. Kakiuchi C, Ishigaki S, Oslowski CM, Fonseca SG, Kato T, and Urano F. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS ONE 4: e4134, 2009.
15. Kannel WB and McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 241: 2035-2038, 1979.
16. Kim AJ, Shi YY, Austin RC, and Werstuck GH. Valproate protects cells from endoplasmic reticulum stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase 3. J Cell Sci 118: 89-99, 2005.
17. Kunjathoor VV, Wilson D, and LeBoeuf RC. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97: 1767-1773, 1996.
18. Lagace DC and Nachtigal MW. Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. J Biol Chem 279: 18851-18860, 2004.
19. Lee JN and Ye J. Proteolytic activation of SREBP induced by cellular stress through the depletion of Insig-1. J Biol Chem 279: 45257-45265, 2004.
20. Lehto S, Ronnemaa T, Pyorala K, and Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinemia predict death from coronary heart disease in patients with Type II diabetes. Diabetologia 43: 148-155, 2000.
21. Li Y, Schwabe RF, Devries-Seimon T, Yao PM, Gerbod-Giannone MC, Tall AR, Davis RJ, Flavell R, Brenner DA, and Tabas I. Free cholesterol-loaded macrophages are an abundant source of TNF-alpha and IL-6. Model of NF-kappa B-and MAP kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 280: 21763-21772, 2005.
22. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
23. Min N and Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641-3651, 2007.
24. Özcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Myers MG Jr, and Özcan U. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9: 35-51, 2009.
25. Özcan U, Cao Q, Yilmaz E, Lee A-H, Iwakoshi NN, Özdelen E, Tuncman G, Görgun C, Glimcher LH, and Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461, 2004.
26. Özcan U, Yilmaz E, Özcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ, and Hotamisligil GS. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313:1137-1140, 2006.
27. Pahl HL. Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol Rev 79: 683-701, 1999.
28. Paigen B, Morrow A, Holmes PA, Mitchell D, and Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68: 231-240, 1987.
29. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern DS, and Schmidt AM. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4: 1025-1031, 1998.
30. Ron D and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-552, 2007.
31. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
32. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, Saunders T, Bonner-Weir S, and Kaufman RJ. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 7: 1165-1176, 2001.
33. Shao L, Sun X, Xu L, Young LT, and Wang JF. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cortical cells. Life Sci. 78: 1317-1323, 2006.
34. Shi Y, Gerritsma D, Bowes AJ, Capretta A, and Werstuck GH. Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition. Bioorg Med Chem Lett. 17: 4491-4494, 2007.
35. Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, and Colbert RA. Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β induction via X-box binding protein 1. Eur J Immunol 38: 194-203, 2008.
36. The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group: intensive diabetes therapy and carotid intima-medial thickness in type 1 diabetes mellitus. N Engl J Med 348: 2294-2303, 2003.
37. Toledo FGS, Sniderman AD, and Kelley DE. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 29: 1845-1850, 2006.
38. Welch WJ and Brown CR. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones. 1: 109-115, 1996.
39. Werstuck GH, Khan MI, Femia G, Kim AJ, Tedesco V, Trigatti B, and Shi YY. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes 55: 93-101, 2006.
40. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, and Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107: 1263-1273, 2001.
41. Yerneni KK, Bai W, Khan BV, Medford RM, and Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48: 855-864, 1999.
42. Zhou J, Lhoták S, Hilditch BA, and Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111: 1814-1821, 2005.
43. Zhou J, Werstuck GH, Lhotak S, de Koning AB, Sood SK, Hossain GS, Moller J, Ritskes-Hoitinga M, Falk E, Dayal S, Lentz SR, and Austin R.C. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice. Circulation 110: 207-213, 2004.